Vol.

No.

March 07, 2025Mar 07, 2025

DOWNLOAD THE PDF

Bhattacharya provides calm answers to anxious questions at confirmation hearing Trump nominee for NIH director calls for transparency, audits of indirect costs

Cover Story

Capitol Hill

Bhattacharya provides calm answers to anxious questions at confirmation hearing

Trump nominee for NIH director calls for transparency, audits of indirect costs

By Jacquelyn Cobb

Amid the flood zone of today’s Washington, the confirmation hearing for Jayanta (Jay) Bhattacharya’s nomination as director of NIH was remarkably calm.

Regulatory News

Trump et al. focus on NIH, cancer—and how peer review is done

By Jacquelyn Cobb, Claire Marie Porter and Paul Goldberg

Clinical

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it

By Claire Marie Porter

Guest Editorial

Raising awareness—for everyone

By W. Kimryn Rathmell

Regeneron Science Talent Search finalists press on at a time of uncertainty

By Yiqing Wang

Harnessing innovation: The next frontier in surgical oncology

By Yuman Fong

Clinical Free Trials & Tribulations

The new therapeutic imperative in cancer management: Sequence, biosimulate, treat

By Michael P. Castro

Free In the Archives

Fred Hutch marks “50 years of doing hard things”

Podcasts

In the Headlines: What are Jay Bhattacharya’s plans for NIH?

In Brief

Jeffrey Rathmell named chair of the UChicago Ben May Department for Cancer Research, director of Ludwig Center for Metastasis Research

Monica Bertagnolli joins Friends of Cancer Research board of directors

Megan Melody joins cellular therapies program at Tampa General Hospital

MD Anderson and Texas Children’s Hospital announce joint venture focused on childhood cancer

MD Anderson receives $9M from F. W. Bert and Mae Dean Wheeler Foundation

RWJBarnabas Health and Rutgers Cancer Institute open breast health center in East Brunswick

IU starts mobile lung cancer screening program

Fred Hutch announces 10 recipients of the annual Harold M. Weintraub Graduate Student Award

Funding Opportunities

Cancer Grand Challenges announces new focus areas for research funding

Clinical Roundup

ASTRO issues first clinical guideline on radiation therapy for anal cancer

CAR T-cell therapy for B-ALL results in high incidence of durable response in phase I/II study

Partial gland removal for prostate cancer patients may avoid recurrence, study shows

Immunotherapy may have potential as prostate cancer treatment, study shows

Rusfertide meets primary endpoint in phase III VERIFY trial for patients with polycythemia vera

Drugs & Targets

FDA approves Tevimbra + chemo for advanced ESCC

University of New England licenses cancer biomarker test to Satya Diagnostics

NCI Trials

NCI Trials for March 2025

The National Cancer Institute approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 51 | Issue 42 - November 14, 2025